Cancer Research:Erectile dysfunction drugs unlikely to cause melanoma ♦ Breath test to diagnose oesophageal, gastric cancer ♦ Tumor initiation, invasion in skin basal cell carcinoma

Big data analysis platform to unveil gene interactions in cancer A breakthrough in cancer genomics has been achieved by developing a novel big data analysis platform for analyzing the interactions among genes. The analysis platform unveils the unregulated patterns of gene network in cancer and discovers potential diagnostic and therapeutic target genes, Nucleophosmin and its associated genes, in Chronic Myelogenous Leukemia

Erectile dysfunction drugs unlikely to cause melanoma A rigorous analysis of more than 20,000 medical records concludes that erectile dysfunction drugs are not a cause of melanoma, an often deadly form of skin cancer.. For the study, researchers matched and analyzed the medical records of men whose care was being monitored in Sweden, one of the few countries in the world taking a population-wide approach to battling melanoma.

New mechanism that regulates tumor initiation, invasion in skin basal cell carcinoma A new mechanism that regulates tumor initiation and invasion in skin basal cell carcinoma. asal cell carcinoma (BCC) is the most common cancer found in human with several million of new patients affected every year around the world.

'Smarter' ordering of breast biomarker tests could save millions in health care dollars A review of medical records for almost 200 patients with breast cancer suggests that more selective use of biomarker testing for such patients has the potential to save millions of dollars in health care spending without compromising care.

Researchers develop new breath test to diagnose oesophageal, gastric cancer A breath test that can help doctors diagnose the early signs of esophageal and gastric cancer in minutes has been developed by researchers. Researchers analysed breath samples of 210 patients using the test.